Antisecretory Factor 16 (AF16): A Promising Avenue for the Treatment of Traumatic Brain Injury-An In Vitro Model

Nicola Vahrmeijer1, Jurgen Kriel2, Bradley M Harrington3

  • 1Department of Physiological Sciences, Stellenbosch University, Merriman Avenue, Mike de Vries Building, Stellenbosch, 7600, South Africa.

Summary

Antisecretory factor (AF16) shows promise for treating traumatic brain injury (TBI). This study found AF16 enhances autophagy and regulates mitochondria, offering neuronal protection post-injury.

Related Concept Videos